Senior insider sale
Chief Medical Officer at UROGEN PHARMA LTD. — senior position signals high conviction
$1.05M
30K shares
What this filing means
SCHOENBERG MARK plans to sell 30K shares of UROGEN PHARMA LTD. valued at approximately $1.05M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/9/2026ACC: 0001000275-26-000093
Officer· Chief Medical Officer
Since Jan 2019
30K
Shares to sell
$1.05M
Approx. market value
10K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
STOCK OPTION EXERCISE
N/A
1/27/2023
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/27/2023 | STOCK OPTION EXERCISE N/A | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
10K
Market value
$350.1K
6/22/2026
—Completed
Units to sell
10K
Market value
$300.0K
5/8/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
10K
Market value
$400.0K
7/9/2026
Total
Units
30K
Value
$1.05M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/22/2026 | 10K | $350.1K | — | Completed |
5/8/2026 | 10K | $300.0K | — | Completed |
| Planned — Approximate Date | ||||
7/9/2026 | 10K | $400.0K | NASDAQ | Planned |
| Total | 30K | $1.05M | ||